RUNCORN, United Kingdom--(BUSINESS WIRE)--Sep 29, 2025--
The Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA), an international organization that advances the use of validated AI solutions in clinical practice, has announced that Epredia, a global leader in precision cancer diagnostics, has won three categories in the 2025 International Scanner Benchmark (ISB) for Epredia’s E1000 Dx Digital Pathology Solution. The ISB recognizes excellence in quality, throughput, and design of digital slide scanning technology for pathology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250924120596/en/
The E1000 Dx consists of a high-speed, automated, whole-slide imaging digital scanner with medical grade viewer and advanced image management and viewer software that creates high-resolution digital images of up to 1,500 tissue samples daily. The E1000 Dx is designed to maximize laboratory throughput and efficiency with technology advancements in sample detection and quality control procedures, which has the potential to make diagnostics more efficient and accurate.
EMPAIA supports regulatory, legal, technical, and organizational pathways to the adoption of validated and certified AI solutions. Through the ISB, EMPAIA seeks to identify the pathology industry’s top image-based diagnostics technologies, which provide detailed digital images that are critical inputs for potential future AI-powered diagnostics.
Epredia’s E1000 Dx won the 2025 ISB in the categories of Quality for digital images at 20x magnification, and Quality and High Throughput for digital images at 40x magnification, the highest level of magnification tested. The honors were based on a comprehensive and objective scanner evaluation, performed on samples from a variety of laboratories across Europe and reviewed by a panel of pathologists. Winners were awarded at the 37th European Congress of Pathology in Vienna, Austria, in September.
Epredia’s E1000 Dx builds on technology originally developed by 3DHISTECH, a leading pathology and diagnostics company and close commercial partner of Epredia. 3DHISTECH also received top honors in the ISB for its Pannoramic 480 Dx digital slide scanner, in the categories of High Throughput for digital images at 20x magnification and Technical capabilities, as well as being recognized with the prestigious Innovator 2025 Award. Epredia is a distributor of the full 3DHISTECH digital pathology portfolio including the Pannoramic 480 Dx.
Steven Lynum, President of Epredia, said, "Digital pathology is the future of cancer diagnostics. As pathology laboratories face greater pressure to speed up processes and reduce costs, we are deeply honored that EMPAIA has recognized the E1000 Dx as a leader in both high throughput and quality. AI holds tremendous potential to enhance the way conditions like cancer are diagnosed and ultimately treated, but AI is only as powerful as the images available to analyze. We look forward to Epredia and 3DHISTECH solutions helping laboratories maximize their digital pathology investment today as well as the potential of this technology to support AI-powered diagnostics in the future."
About Epredia
Epredia is a global leader in the anatomical pathology field, providing comprehensive solutions for precision cancer diagnostics and tissue diagnostics. Powered by key brands, including Erie Scientific, Menzel-Gläser, Microm, Shandon, and Richard-Allan Scientific, Epredia’s portfolio includes microscope slides, instruments and consumables. Epredia was established following the acquisition of Thermo Fisher Scientific’s Anatomical Pathology business by PHC Holdings Corporation (TSE 6523) in 2019. Epredia has operations in major sites in the United States, the United Kingdom, Germany and China with a total of around 1,200 employees. Epredia is committed to achieving its mission to improve lives by enhancing cancer diagnostics for patients around the world. For further information on Epredia and its products, please visit www.epredia.com.
About PHC Holdings Corporation (PHC Group)
PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries (referred to collectively as PHC Group) include PHC Corporation, Epredia, Ascensia Diabetes Care, LSI Medience Corporation, Wemex and Mediford. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, life sciences and diagnostics. PHC Group’s consolidated net sales in FY2024 were JPY 361.6 billion with global distribution of products and services in more than 125 countries.
www.phchd.com
Epredia’s E1000 Dx Digital Pathology Solution Wins 2025 International Scanner Benchmark Awards from the Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA)
PHILADELPHIA (AP) — The Eagles need a new offensive coordinator.
Ask most fans, commentators — and, privately, some players — and the change from Kevin Patullo was inevitable long before Philadelphia actually made the move this week in the wake of a playoff loss.
There's a “help wanted” sign for the new boss of an offense — one loaded with elite talent such as Jalen Hurts, Saquon Barkley, A.J. Brown and DeVonta Smith — that fell way short as the Eagles failed in their bid to win consecutive Super Bowl titles.
Coach Nick Sirianni and general manager Howie Roseman were vague on details Thursday about why they waited until the end of the season to make the move — the Eagles ranked 24th in yards per game (311) and 19th in points per game (19.3) — and less clear on what they wanted out of a new coordinator.
“You’re looking to continue to evolve as an offense, and I’m looking to bring in the guy that’s going to best help us do that,” Sirianni said. “I think that there are many different ways to be successful on offense and everybody has different styles, everybody has different players, and there’s many different ways to be successful.”
The Eagles have plenty of credible candidates to choose from — everyone from Josh McCown and Cam Turner to former NFL coaches Brian Daboll, Mike McDaniel and Kliff Kingsbury. The new OC could have complete autonomy to run the offense, though collaboration has been key under Sirianni.
No matter the coordinator, the Eagles expect to be contenders again after playing in two of the last four Super Bowls. Just winning an NFC East title doesn't cut it these days in Philly.
“If it doesn’t end with confetti falling on our heads, I don’t feel like it’s good enough,” Roseman said. “I know that we’re not going to win the Super Bowl every year. I think I know that from a broad perspective, but I believe we can. I go into every offseason thinking we’re going to do whatever it takes to win a Super Bowl.”
Two-time All-Pro offensive tackle Lane Johnson has built a Hall of Fame-level career and won two Super Bowls since the Eagles made him a 2013 first-round pick.
Retirement talk was a hot topic for most of the season.
Johnson turns 36 in May and did not play after Week 11 because of a foot injury. He did not talk to the media this week when the Eagles cleaned out their lockers.
Roseman kept private his conversation with Johnson about retirement. Johnson reworked his contract last May and is signed through 2027.
“You're talking about a Hall of Fame player who’s been a huge, huge part of any of our success that we’ve had, and when you watch him play, he’s still playing at an elite level,” Roseman said.
Brown is likely staying put.
While he isn't shy about airing his grievances, the wide receiver is often worth the distractions because of his production.
Just not this season.
Brown had 78 receptions (down from 106 in 2023) for 1,003 yards (he had 1,496 in 2022) and only five 100-yard games. Of course, some of that dip in production resulted from how he was used in Patullo's offense. The changes ahead are one reason why the Eagles are in no rush to give up on the 28-year star — along with the $43 million dead salary cap hit they'd take if Brown wasn't on the roster.
“It is hard to find great players in the NFL and A.J.’s a great player,” Roseman said. “I think from my perspective, that’s what we’re going out and looking for when we go out here in free agency and in the draft is trying to find great players who love football, and he’s that guy. I think that would be my answer.”
Special teams coach Michael Clay had a virtual interview Thursday for the same job with the Tampa Bay Buccaneers.
Sirianni also hasn't ruled out Patullo staying on the staff in a different role.
“I know Kevin’s going to have other opportunities, and obviously always want what’s best for Kevin and for his family, so we’ll see how that plays out,” Sirianni said.
Patullo could want a fresh start after his house was egged earlier this season and one area indoor golf establishment let fans hit golf balls into a photo of his face after the playoff loss.
AP NFL: https://apnews.com/hub/nfl
Philadelphia Eagles head coach Nick Sirianni speaks with the media during a news conference at the NFL football team's training facility, Thursday, Jan. 15, 2026, in Philadelphia. (AP Photo/Chris Szagola)
Philadelphia Eagles head coach Nick Sirianni speaks with the media during a news conference at the NFL football team's training facility, Thursday, Jan. 15, 2026, in Philadelphia. (AP Photo/Chris Szagola)
Philadelphia Eagles executive vice president and general manager Howie Roseman, left, looks over as head coach Nick Sirianni, right, speaks with the media during a news conference at the NFL football team's training facility, Thursday, Jan. 15, 2026, in Philadelphia. (AP Photo/Chris Szagola)
Philadelphia Eagles head coach Nick Sirianni, right, and executive vice president and general manager Howie Roseman, left, speaks with the media during a news conference at the NFL football team's training facility, Thursday, Jan. 15, 2026, in Philadelphia. (AP Photo/Chris Szagola)
Philadelphia Eagles head coach Nick Sirianni speaks with the media during a news conference at the NFL football team's training facility, Thursday, Jan. 15, 2026, in Philadelphia. (AP Photo/Chris Szagola)
